Solid Tumors
A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients with Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) (PMV-586-101)
- Details
ClinicalTrials.gov ID:
NCT04585750
Diagnosis Type:
NA
USOR Number:
- Address
,
P: